Cop 1 is a synthetic basic random copolymer of L-alanine, L-glutamic acid, L-lysine, and
Experimental allergic encephalomyelitis (EAE) is a Tcell-mediated autoimmune disease of the central nervous system which serves as an animal model for human demyelinating diseases, including multiple sclerosis (1) . Cop 1 is a synthetic random copolymer of amino acids which proved to be effective in specific suppression of EAE induced in various animal species (2) (3) (4) (5) (6) . It was also demonstrated to be effective in reducing the number of relapses in early exacerbating-remitting multiple sclerosis (7) .
The basis for the biological activity of Cop 1 lies in its immunological cross reactivity with myelin basic protein (BP) , which is the autoantigen in EAE. This cross reactivity was well established at the level of T-cell-mediated immunity (8, 9) and at the level of humoral response, by using monoclonal antibodies (6) . Furthermore, in mice, Cop 1 was found to induce suppressor cells specific to BP which mediate protection against EAE (5). This may be a possible mechanism for the protective activity of Cop 1. Nonetheless, some of our early studies suggest that additional immunological mechanisms may also be involved in the suppressive activity of Cop 1. In our studies on the cross reactivity between BP and Cop 1 at the cellular level with the lymphocyte transformation assay of in vivo-sensitized lymphocytes from guinea pigs and rabbits, we observed in certain systems direct cross stimulation, while in others, a specific cross inhibition was detected (8) . Inhibition by Cop 1 of the response to BP was also observed in an in vitro-sensitization system, where Cop 1 inhibited the induction of BP-specific cells from normal lymphocytes (10) .
The development of in vitro-propagating antigen-specific T-cell lines and clones made a major contribution to the elucidation of the mechanisms of the cellular interactions involved in the immune response in general (11) and in EAE in particular (12) . In the present study we have utilized this powerful tool to further investigate the ability of Cop 1 to inhibit the specific T-cell response to BP. We report here that Cop 1 inhibited several BP-specific murine T-cell lines and clones with various H-2 restrictions and antigenic specificities. These findings may suggest an additional or alternative mechanism for Cop 1 suppressive activity in EAE.
MATERIALS AND METHODS Mice. B10.PL mice were obtained from The Jackson Laboratory. BALB/K and (SJL/J x BALB/K)F1 mice were obtained from Harlan-Olac (Bicester, England). Mice were used at the age of 6-12 weeks.
Antigens. The BP was isolated from spinal cords of rats, mice, and bovines, as described (13) .
The synthetic peptides pR1-11, pR5-16, and pR35-47 of rat BP (RBP) were a gift from Lawrence Steinman (Stanford University).
Purified protein derivative (PPD) of tuberculin was obtained from Statens Serum Institute (Copenhagen, Denmark).
The synthetic antigens: Cop 1, composed of L-alanine, L-glutamic acid, L-lysine, and L-tyrosine in a residue molar ratio of 6.0:1.9:4.7:1.0 and with molecular weight of 21, 000 (2); D-Cop 1, similar to Cop 1 in composition but composed of D-amino acids (9) ; and TGA, a random polymer of L-tyrosine, L-glutamic acid, and L-alanine [poly(Tyr,Glu, Ala)] in a residue molar ratio of 2.0:1.0:1.0 (14) , were synthesized and characterized as described.
T-Cell Lines and Clones. T-cell lines were derived from lymph node or spleen cells of mice immunized with RBP in complete Freund's adjuvant and selected in vitro by using either RBP or PPD as described by Ben-Nun and Lando (15) . The cells were propagated in culture with 10% (vol/vol) T-cell growth factor (termed T-cell growth factor/Con Ainduced murine spleen cell culture fluid), with exposure to After a 24-hr incubation, 1 ,uCi of [3Hlthymidine was added for 5 hr. The cultures were further processed as described above. Inhibition Studies. Inhibition of the T-cell proliferative activity and IL-2 secretion was studied by adding various concentrations of the tested inhibitors plus the stimulating antigen to the assay system. Inhibition was calculated as: % inhibition = (1 -cpm in the presence of inhibitor/cpm in the absence of inhibitor) x 100. RESULTS T-Cell Lines and Clones. Several T-cell lines and clones, listed in Table 1 , with various H-2 restrictions and antigenic specificities, were used to study the effect of Cop 1 on the T-cell response to BP. Four clones (Bu-6, -10, -19, and -20) were derived from a line derived from lymph node cells of B1O.PL mice immunized with RBP in complete Freund's adjuvant. Although all the clones respond to RBP, they reflect different specificities. Clones Bu-6 and -20 respond also to mouse BP (MBP) and bovine BP (BBP), and they recognize peptide pR1-11, which constitutes the encephalitogenic determinant in H-2U mice (16) . In contrast, clones Bu-10 and -19 did not respond to pR1-11 nor to any of the other H-2u-lihked determinants-i.e., pR5-16 and pR35-47 Proc. Natl. Acad. Sci. USA 85 (1988) 9725 (16) A third source of RBP-specific lines was the BALB/K strain of mice which is EAE-resistant under normal conditions but can be converted to EAE sensitivity after treatment with a low dose of cyclophosphamide (17) . The line developed from spleen cells of these RBP-immunized mice, denoted B-K-Sp, is reactive only with RBP ( Table 1) .
Inhibition of BP-Specific H-2u-Restricted T-Cell Clones by Cop 1. The specific response of the T-cell clones was followed either by their proliferative activity or IL-2 secretion. None of these clones could be directly stimulated by Cop 1. The effect of Cop 1 on the response of the four BP-specific T-cell clones of H-2U origin was, therefore, evaluated by their capacity to inhibit the response to BP. The T-cell clones were incubated with various concentrations of BP and Cop 1.
The results with a representative clone, Bu-6, are shown in Fig. 1 . Cop 1 inhibited RBP activation of clone Bu-6 in a competitive dose-dependent manner. As can be seen (Fig.  LA) , 50% inhibition of the proliferative response to RBP could be obtained by using an =2-fold molar excess of Cop 1, when tested in the linear phase of the dose-response curve of RBP, and up to 96% inhibition was obtained by using a 10-fold molar excess of Cop 1. The response of this clone to RBP, as followed by IL-2 secretion, could also be inhibited with Cop 1, with a similar efficiency and profile as in the proliferation assay (Fig. 1B) . The inhibition of the response to BP was specific to Cop 1, as D-Cop 1, and another random polymer TGA, both of which were shown (2, 9) to be ineffective in EAE suppression, did not inhibit the response to BP (Fig. 1A) . Furthermore, Cop 1 specifically inhibited only the responses td RBP and MBP of the T-cell clone and did not inhibit the response to the mitogen Con A (Fig. 1C) . The effect of Cop 1 was then tested on the other three BP-specific T-cell clones of H-2U origin, as well as on the PPD-specific T-cell clone of H-2u origin, PPU-4. The results, summarized in (Fig. 2) . TGA caused neither inhibition nor enhancement. The response to Con A of all these T-cell lines was not affected by Cop 1, and Cop 1 also had no effect in the PPD cell line of H-2sk origin-i.e., PP-SK-Sp (data not shown).
The dose-response curve ofthe inhibition by Cop 1 in these T-cell lines, as demonstrated in Fig. 3 for the B-SK-LN line, illustrates similar characteristics of dose-dependent inhibition as in the H-2U clones. Inhibition of the proliferative response by 50% was obtained at a 5-fold molar excess of Cop 1, with a maximal inhibition of 79.5% (Fig. 3A) . Among these T-cell lines only cell line B-SK-LN was found to release IL-2 in response to T-cell activation. Cop 1 inhibited the IL-2 release induced by RBP, up to 80% with a 4-fold molar excess of Cop 1, whereas TGA had no effect (Fig. 3B) . 
DISCUSSION
The study described here was undertaken to further establish whether Cop 1, which is an efficient suppressive agent in EAE and possibly in multiple sclerosis, is capable of blocking specific T-cell responses to BP. We have demonstrated (8) that Cop 1 can inhibit the response to BP of sensitized lymphocytes from strain 13 guinea pigs and rabbits. Furthermore, Cop 1 inhibited the in vitro induction of BP-specific cells from normal lymphocytes (10) . In the present study, these observations were corroborated at the level of specific T-cell lines and clones of defined specificities and H-2 restrictions. Indeed, Cop 1 specifically inhibited the response Cop 1 inhibited the response of several T-cell lines and clones which probably respond to different epitopes of the basic protein-i.e., they represent different T-cell receptor (TCR) specificities. For the four H-2u-restricted BP-specific clones, two respond to the same epitope, pR1-11, which is the encephalitogenic determinant in H-2U strains of mice, as demonstrated by Zamvil et al. (16) . Those two clones are inhibited by Cop 1 but with different efficiencies (Table 2) , which may indicate differences in the affinity of the TCR for BP. The other two clones, Bu-10 and -19, respond to yet undefined epitopes of the BP. These two clones differ in their response to BBP, which might reflect response to different determinants. Therefore, we have four clones which represent at least three TCR specificities and they are all inhibited by Cop 1. For BP-specific lines derived from H-2sk and H-2k mice, their exact epitope specificity has not yet been determined; however, they represent at least two specificities as reflected by the differences in response to MBP. One possibility might be the T-cell epitopes characterized by Sakai et al. (18) for H-2s clones-i.e., within residues 89-101 of RBP. Of four lines, one was capable of proliferating in response to Cop 1, whereas the other three lines were inhibited by Cop 1 to various degrees (Fig. 2) . These in vitro findings with the BP-specific T-cell lines and clones are in accord with the observed in vivo-suppressive activity of Cop 1 in a variety of species (mice, guinea pigs, rabbits, and monkeys) (2-6) which respond to different encephalitogenic determinants on BP (19) . The mechanism by which Cop 1 specifically inhibits the response of T-cell lines and clones with different TCRs to BP is not yet clear. The TCR recognizes only peptide fragments bound to a self major histocompatibility complex (MHC) molecule. A given T cell is both peptide-specific and MHCrestricted (21) . It appears that class II MHC molecules possess only one major peptide binding site that has high affinity but paradoxically low specificity for peptides (22 
